Kawamura Yoichi, Takeshita Seiichiro, Kanai Takashi, Takizawa Mari, Yoshida Yusuke, Tsujita Yuki, Nonoyama Shigeaki
Department of Pediatrics, National Defense Medical College, Tokorozawa, Saitama, Japan.
Division of Nursing, National Defense Medical College, Tokorozawa, Saitama, Japan.
Int J Pediatr. 2017;2017:4162597. doi: 10.1155/2017/4162597. Epub 2017 Feb 28.
Abnormal urinary findings, such as sterile pyuria, proteinuria, and microscopic hematuria, are often seen in the acute phase of Kawasaki disease (KD). We investigated the potential significance of urinary lactate dehydrogenase (U-LDH) activity and its isozyme patterns in KD. Total U-LDH activity and its isozymes (U-LDH1-5) levels were compared among 120 patients with KD, 18 patients with viral infection (VI), and 43 patients with upper urinary tract infection (UTI) and additionally compared between intravenous immunoglobulin (IVIG) responders ( = 89) and nonresponders ( = 31) with KD. Total U-LDH activity was higher in KD (35.4 ± 4.8 IU/L, < 0.05) and UTI patients (66.0 ± 8.0 IU/L, < 0.01) than in VI patients (17.0 ± 6.2 IU/L). In the isozyme pattern analysis, KD patients had high levels of U-LDH1 and U-LDH2, while UTI patients had high levels of U-LDH3, U-LDH4, and U-LDH5. Furthermore, IVIG nonresponders of KD had significantly higher levels of total U-LDH activity (45.1 ± 4.7 IU/L, < 0.05), especially U-LDH1 and U-LDH2 ( < 0.05), than IVIG responders (32.0 ± 2.8 IU/L). KD patients have increased levels of total U-LDH activity, especially U-LDH-1 and U-LDH2, indicating a unique pattern of U-LDH isozymes different from that in UTI patients.
异常的尿液检查结果,如无菌性脓尿、蛋白尿和镜下血尿,在川崎病(KD)急性期较为常见。我们研究了尿液乳酸脱氢酶(U-LDH)活性及其同工酶谱在KD中的潜在意义。比较了120例KD患者、18例病毒感染(VI)患者和43例上尿路感染(UTI)患者的总U-LDH活性及其同工酶(U-LDH1-5)水平,并进一步比较了KD患者中静脉注射免疫球蛋白(IVIG)反应者(n = 89)和无反应者(n = 31)的情况。KD患者(35.4±4.8 IU/L,P < 0.05)和UTI患者(66.0±8.0 IU/L,P < 0.01)的总U-LDH活性高于VI患者(17.0±6.2 IU/L)。在同工酶谱分析中,KD患者的U-LDH1和U-LDH2水平较高,而UTI患者的U-LDH3、U-LDH4和U-LDH5水平较高。此外,KD患者中IVIG无反应者的总U-LDH活性水平(45.1±4.7 IU/L,P < 0.05)显著高于IVIG反应者(32.0±2.8 IU/L),尤其是U-LDH1和U-LDH2(P < 0.05)。KD患者的总U-LDH活性水平升高,尤其是U-LDH-1和U-LDH2,表明其U-LDH同工酶谱与UTI患者不同。